Listar por autor "Guerrero, Mercedes"
Mostrando ítems 1-2 de 2
-
Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: the single-center INEOX randomized controlled trial.
Ruiz de Adana Navas, María Soledad; Domínguez, Marta Elena; Morillas, Virginia; Colomo, Natalia; Vallejo Mora, María del Rosario; Guerrero, Mercedes; García-Escobar, Eva; Carreira-Soler, Mónica
; Romero-Zerbo, Silvana Yanina; Linares, Francisca; González-Mariscal, Isabel; Bermúdez Silva, Francisco Javier; Olveira-Fuster, Gabriel María; Rojo-Martínez, Gemma[et al.] (Elsevier, 2023)
Aims To compare efficacy and safety of degludec 100 IU/mL (Deg-100) and glargine 300 IU/mL (Gla-300) in adults with type 1 diabetes. Methods Open-label, single-center, randomized, parallel-group, 24-week trial in adults ... -
Telemedicine, Psychology and Diabetes: Evaluation of results and cost analysis
Anarte-Ortiz, María Teresa; Carreira-Soler, Mónica; González-Álvarez, María Luz; Colomo Rodríguez, Natalia; Domínguez-López, Marta Elena; Machado Romero, Alberto; Esteva de Antonio, María Isabel; Valdés, Sergio; Tapia Guerrero, María José; Sánchez, Isabel; Guerrero, Mercedes; Olveira-Fuster, Gabriel María; Ruiz de Adana Navas, María Soledad[et al.] (2015-04-21)
AIMS: Evidences of benefits of telemedicine in T1DM patients on continuous subcutaneous insulin infusion (CSII) treatment are limited. Aims: 1) to analyse the differences in clinical and psychological variables between ...